- Report
- October 2023
- 89 Pages
Canada
From €3364EUR$3,500USD£2,885GBP
- Report
- October 2021
- 39 Pages
Global
- Report
- November 2018
- 59 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- March 2018
- 15 Pages
Global
- Report
- October 2019
- 241 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- August 2022
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- January 2022
- 90 Pages
Europe
From €4565EUR$4,750USD£3,915GBP
- Report
- January 2022
- 115 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- May 2020
- 72 Pages
Asia Pacific
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 110 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- August 2020
- 90 Pages
United States
From €3124EUR$3,250USD£2,679GBP
- Report
- July 2021
- 120 Pages
Global
From €3941EUR$4,100USD£3,379GBP
- Report
- June 2019
- 116 Pages
Global
From €4277EUR$4,450USD£3,668GBP
- Report
- March 2022
- 40 Pages
Saudi Arabia
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 40 Pages
India
From €2494EUR$2,595USD£2,139GBP
- Report
- March 2022
- 100 Pages
Global
From €4609EUR$4,795USD£3,952GBP
- Report
- April 2022
- 120 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,236GBP
- Report
- April 2022
- 325 Pages
Global
From €3460EUR$3,600USD£2,967GBP
- Report
- April 2022
- 120 Pages
Europe
From €1442EUR$1,500USD£1,236GBP
- Report
- April 2022
- 101 Pages
North America
From €1442EUR$1,500USD£1,236GBP
Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more